Overall, flavonols display significant antitumor efficacy in RCC by modulating key cellular processes and signaling pathways, including EGFR/p38, PI3K/Akt, JAK/STAT3, and ferroptosis-related targets. This evidence concerns the gene AKT1 and renal cell carcinoma.